Geovax Labs (GOVX) Stock Price, Quote & News

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology

Sector: Healthcare

Phone: (678) 384-7220

Fax: (678) 384-7281

Website: www.geovax.com

Address:

1900 Lake Park Drive, Suite 380, Smyrna, United States

TraderUKBoyy Jun. 25 at 6:03 AM

$GOVX And that’s a miracle close and green after hours 🤩🥸 Let’s close above $0.95 today !!

0 · Reply

DavidScott Jun. 25 at 3:21 AM

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $BBAI $GEVO $PHUN $FUBO $GOVX

1 · Reply

Ueberschlaefer Jun. 24 at 8:49 PM

$GOVX EYEN cracked $9 on its crypto conversion. GOVX will see $9 after some god awful RS. that's coming. then it will continue to burn piles of cash in the backyard while grandpa dave sips cocktails and tends the weenies on the grill.

0 · Reply

GoGetters25 Jun. 24 at 5:30 PM

$GOVX

0 · Reply

ChasingtheLambo Jun. 24 at 4:42 PM

$GOVX Come on mama ! Climb volumes picking up

0 · Reply

ChasingtheLambo Jun. 24 at 3:17 PM

$GOVX Still hitting it hard and averaging down …

0 · Reply

Ueberschlaefer Jun. 24 at 3:09 PM

$GOVX EYEN, another failed biotech, pivoted to crypto and its stock is now over $8. GOVX has proven for 37 years that it sucks at doing medical shit; it's time to move to crypto. companies in late imperialist capitalist empires could do worse than by hedging against fiat. while i bust $SBET because it's a shit company for gambling, GOVX can only continue on as a wealth-destroying enterprise that produces nothing if it remains on its current course.

0 · Reply

TraderUKBoyy Jun. 24 at 2:20 PM

$GOVX $GOVX This had never seen this aggressive red candles in the recent past !! On the way to hit 52 weeks low in 0.70’s if no PR from company !!! Hope for some miracle !! 0.85 so far lows of recent past .. Daily candles not looking good 😔

0 · Reply

To_De_Moon Jun. 24 at 2:18 PM

$GOVX https://www.linkedin.com/posts/geovax-inc-_immunotherapy-biotech-ugcPost-7343277716101656576-E7Kl?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAWToJoBEnvflDrmncoF71z330hCQVZWnVg&utm_campaign=copy_link

0 · Reply

makedatbread88 Jun. 24 at 2:00 PM

$GOVX interesting down here below $1

0 · Reply

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 3 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Dec 9, 2024, 9:00 AM EST - 7 months ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Nov 26, 2024, 9:00 AM EST - 7 months ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 12, 2024, 11:33 PM EST - 8 months ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:00 PM EST - 8 months ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 5, 2024, 9:00 AM EST - 8 months ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Oct 2, 2024, 9:00 AM EDT - 9 months ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 3, 2024, 9:00 AM EDT - 10 months ago

GeoVax to Participate in Upcoming Investor Conferences in September

Aug 28, 2024, 8:59 PM EDT - 10 months ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 20, 2024, 8:09 AM EDT - 11 months ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 7:45 AM EDT - 11 months ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:00 AM EDT - 11 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

Aug 19, 2024, 7:30 AM EDT - 11 months ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 15, 2024, 9:00 AM EDT - 11 months ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 8:36 AM EDT - 11 months ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

Aug 10, 2024, 6:15 AM EDT - 11 months ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 9:00 AM EDT - 11 months ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 6, 2024, 4:00 PM EDT - 11 months ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 31, 2024, 10:15 AM EDT - 11 months ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

Apr 4, 2024, 12:30 PM EDT - 1 year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Mar 28, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 12, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the 36th Annual Roth Conference

Mar 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 1, 2024, 2:34 AM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 22, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 19, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 13, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Jan 29, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 8, 2024, 9:00 AM EST - 1 year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 4, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 3, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

Dec 27, 2023, 9:00 AM EST - 1 year ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 19, 2023, 9:00 AM EST - 1 year ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Nov 30, 2023, 4:30 PM EST - 1 year ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 29, 2023, 9:00 AM EST - 1 year ago

GeoVax to Participate in Upcoming December Investor Events

Nov 28, 2023, 9:00 AM EST - 1 year ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 14, 2023, 9:00 AM EST - 1 year ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 8, 2023, 9:26 PM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:00 PM EST - 1 year ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Oct 30, 2023, 9:00 AM EDT - 1 year ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 25, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 24, 2023, 9:00 AM EDT - 1 year ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 9, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Sep 27, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming October Investor and Industry Events

Sep 20, 2023, 9:00 AM EDT - 1 year ago

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

TraderUKBoyy Jun. 25 at 6:03 AM

$GOVX And that’s a miracle close and green after hours 🤩🥸 Let’s close above $0.95 today !!

0 · Reply

DavidScott Jun. 25 at 3:21 AM

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $BBAI $GEVO $PHUN $FUBO $GOVX

1 · Reply

Ueberschlaefer Jun. 24 at 8:49 PM

0 · Reply

GoGetters25 Jun. 24 at 5:30 PM

$GOVX

0 · Reply

ChasingtheLambo Jun. 24 at 4:42 PM

$GOVX Come on mama ! Climb volumes picking up

0 · Reply

ChasingtheLambo Jun. 24 at 3:17 PM

$GOVX Still hitting it hard and averaging down …

0 · Reply

Ueberschlaefer Jun. 24 at 3:09 PM

0 · Reply

TraderUKBoyy Jun. 24 at 2:20 PM

0 · Reply

To_De_Moon Jun. 24 at 2:18 PM

0 · Reply

makedatbread88 Jun. 24 at 2:00 PM

$GOVX interesting down here below $1

0 · Reply

jmoneyHungry Jun. 24 at 9:29 AM

$GOVX You're not, it is just so blatantly clear how this company has screwed their shareholders over and over and over again(x10) that only the most tism'd is still here lying to others or themselves.

0 · Reply

PapaRoki Jun. 23 at 11:06 PM

$GOVX cheapies for the weapies

0 · Reply

Ueberschlaefer Jun. 23 at 5:03 PM

$GOVX i must be blocked by every pumptard on this board. i see very few green messages being passed, or stockbots has a serious problem with their indicators. 🤣

0 · Reply

TraderUKBoyy Jun. 23 at 4:22 PM

$GOVX This needs a solid PR at the earliest… hitting a new low of past one month.. if no recovery next leg down to 0.70’s :-( One solid PR and this will fly ..

0 · Reply

Beanie_Mojo Jun. 23 at 2:48 PM

$GBR Only green 🍏 🔥📈 Power in play. ▶️ push higher towards dbl digits. $SRM $GOVX $HOLO

0 · Reply

geniuscali Jun. 23 at 1:39 PM

$GOVX ouch

1 · Reply

lealbinagor98 Jun. 23 at 9:54 AM

$GNLN let's up, another interesting asset with good potential $WINT $NVAX $GOVX ⏰️🔥🚀🫡

0 · Reply

DavidScott Jun. 23 at 3:07 AM

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $HOLO $NNVC $WWR $GOVX $CLOV

2 · Reply

StoxWise369 Jun. 22 at 12:07 PM

$GOVX Should've sold my 975327987675555 shares at 50000000 ten years ago 🤨🥺🥹🤨😡😤😤😤

0 · Reply

lealbinagor98 Jun. 22 at 4:10 AM

$GNLN A good buildup, is it going up again? It has a great analyst rating... let's wait and see ⏰️🚀😎👋🔥 $NVAX $GOVX

2 · Reply

ChasingtheLambo Jun. 22 at 2:38 AM

$GOVX This is the future!!!!!!! Like next week !!!!

0 · Reply

ChasingtheLambo Jun. 22 at 2:37 AM

$GOVX Keep reporting these people spamming our board with $GEAT hitting the scanners … watch it burn in flames on Monday … stop cross thread posting junk stocks … GOVX IS THE PROVEN WINNER

1 · Reply

Market Cap	13.29M
Revenue (ttm)	3.95M
Net Income (ttm)	-24.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-632.66%
Debt to Equity Ratio	0.00

Volume	1,503,800
Avg Vol	829,402
Day's Range	N/A - N/A
Shares Out	15.19M
Stochastic %K	10%
Beta	3.45
Analysts	Strong Sell
Price Target	$10.70